Anaphase
The decisive stage of chromosome segregation — separase activation, cohesin cleavage, anaphase A kinetochore microtubule shortening, anaphase B spindle elongation, APC/C-Cdc20 regulation, motor protein mechanics, lagging chromosomes, anaphase bridges, and the distinct anaphase programmes of meiosis I and meiosis II.
Anaphase is the culminating act of chromosome segregation — the moment when sister chromatids or homologous chromosomes, held together since their replication, are physically pulled apart and directed to opposite ends of the cell. In terms of duration, it is one of the briefest stages of mitosis, typically lasting three to five minutes in cultured human cells. In terms of consequence, it is the most irreversible: the instant separase cleaves centromeric cohesin, the cell has irrevocably committed to a specific chromosome distribution between its two daughters. Every error that slips through the preceding checkpoints is amplified and fixed at anaphase. Understanding this phase in molecular detail — not as a visual observation of chromosomes moving apart but as a precisely regulated sequence of enzymatic, mechanical, and biophysical events — is the foundation for understanding chromosomal instability, cancer, and the age-related reproductive errors that produce aneuploid embryos.
Prophase
Condensation, spindle nucleation
Prometaphase
NEB, kinetochore capture, SAC
Metaphase
Chromosome alignment, biorientation
Anaphase
Cohesin cleavage, chromatid separation, pole movement
Telophase
Decondensation, NE reformation
Cytokinesis
Cytoplasm division
What Anaphase Is and Its Functional Position in the Cell Division Programme
Anaphase (from the Greek ana, meaning “back” or “again”) is the stage of mitosis and meiosis during which replicated chromosomes are physically separated and transported to opposite poles of the dividing cell. It follows metaphase — during which chromosomes have aligned at the metaphase plate with each kinetochore attached to microtubules from the nearest spindle pole (amphitelic or bioriented attachment) — and precedes telophase, during which the nuclear envelope reforms around the two separated chromosome sets.
Anaphase is not a single mechanism but the coordinated output of multiple simultaneous processes: the biochemical switch of cohesin cleavage that releases chromosomes, the mechanical process of kinetochore microtubule shortening that moves chromosomes poleward, the physical process of spindle pole separation that increases the distance between the two chromosome sets, and the regulatory process of CDK1 inactivation that begins the transition to mitotic exit. Each of these processes is molecularly distinct, independently regulated, and yet precisely synchronised — because the segregation errors that produce aneuploid daughter cells arise when any one process is mistimed relative to the others.
The Metaphase-to-Anaphase Transition: A Timed, Irreversible Molecular Switch
The transition from metaphase to anaphase is one of the most consequential state changes in cell biology — converting a cell in which chromosomes are balanced under equivalent tension from both poles into one in which those same chromosomes are irrevocably committed to a specific daughter cell. It is not a gradual process but a switch-like transition driven by the rapid, proteasome-mediated degradation of two key inhibitory proteins: securin (the inhibitor of separase) and Cyclin B1 (the activating subunit of CDK1). Both are substrates of the same ubiquitin ligase — APC/C-Cdc20 — whose activation is therefore the single biochemical trigger for anaphase onset.
Why the Transition Must Be Switch-Like — Not Gradual
If cohesin were cleaved gradually — a fraction of chromosomes separating while others remain attached — the result would be a catastrophic mixed state: some chromosomes moving poleward while others remain at the plate, producing unequal chromosome distribution in any cell that divided before all chromosomes were released. The switch-like, near-simultaneous cleavage of all cohesin molecules is therefore not incidental but a functional requirement of accurate chromosome segregation.
This switch behaviour is achieved through positive feedback: APC/C-Cdc20 activity rises rapidly once the SAC is satisfied (because Cdc20 is continuously being produced but was previously being sequestered by the MCC); as securin levels fall, separase becomes active on the first cohesin molecules it encounters; the resulting tension change as chromosomes begin separating further silences any residual kinetochore-based SAC signals; and Cyclin B1 degradation removes CDK1 phosphorylation from multiple substrates simultaneously — producing a coherent, all-at-once transition rather than a piecemeal one. Computational modelling of this circuit confirms bistable switch behaviour: the system resists partial anaphase states and snaps from metaphase to anaphase without spending significant time in intermediate configurations.
APC/C-Cdc20: The Ubiquitin Ligase That Licenses Anaphase
The Anaphase-Promoting Complex/Cyclosome (APC/C) is a 1.2 MDa multi-subunit E3 ubiquitin ligase — among the largest protein complexes in the eukaryotic cell — that controls the transition from metaphase to anaphase and the subsequent exit from mitosis by targeting key regulatory proteins for proteasomal degradation. Its name reflects its two defining properties: it promotes anaphase and it cycles between active and inactive states in a cell-cycle-coordinated manner.
APC/C INHIBITION (Metaphase — SAC active): MCC (Mad2 + BubR1 + Bub3 + Cdc20) → sequesters Cdc20, blocks APC/C-Cdc20 Emi1 (interphase) → pseudo-substrate inhibitor of APC/C Result: Securin and Cyclin B1 stable → Separase inhibited, CDK1 active SAC SATISFACTION (all kinetochores bioriented under tension): Dynein strips Mad1/Mad2 from kinetochores along k-MTs PP1/PP2A at kinetochores reverse Aurora B-dependent SAC phosphorylations MCC dissociates → Cdc20 is free to activate APC/C APC/C-CDC20 ACTIVATION → ANAPHASE ONSET: Target 1: SECURIN (PTTG1) APC/C-Cdc20 polyubiquitinates via D-box (RXXL) degron Proteasome degrades securin → separase LIBERATED Separase cleaves RAD21/Rec8 kleisin subunit of cohesin Cohesin ring opens → centromeric cohesion released → ANAPHASE BEGINS Target 2: CYCLIN B1 APC/C-Cdc20 polyubiquitinates via D-box degron Proteasome degrades Cyclin B1 → CDK1 INACTIVATES CDK1 substrates dephosphorylated by PP1/PP2A Triggers: NE reformation, chromosome decondensation, cytokinesis onset Note: Securin and Cyclin B1 are degraded nearly simultaneously APC/C-Cdh1 takes over in late mitosis/G1 for sustained CDK1 suppression
Separase: Architecture, Activation, and the Cleavage of Cohesin
Separase is a 230 kDa cysteine protease — conserved from yeast (Esp1) to humans (ESPL1) — that executes the single most consequential proteolytic cleavage event in cell division: cutting the Rad21 (Mcd1/Scc1) kleisin subunit of cohesin to open the cohesin ring and release sister chromatid cohesion. Its activity is tightly controlled by two independent inhibitory mechanisms that must both be relieved for full separase activation at the metaphase-to-anaphase transition.
Securin — The Stoichiometric Inhibitor
Securin (PTTG1 in mammals; Pds1 in budding yeast) binds separase 1:1 and inhibits its protease activity through a pseudosubstrate mechanism — its C-terminal segment occupies the separase active site cleft, preventing substrate access. Securin is degraded by APC/C-Cdc20 at the metaphase-to-anaphase transition. As securin levels fall, the separase active site is progressively unblocked. Importantly, securin is not merely a brake — it also acts as a chaperone for proper separase folding and nuclear localisation. Cells completely lacking securin (securin knockouts) are viable in culture because CDK1-dependent separase phosphorylation provides a redundant inhibitory mechanism, but they show elevated chromosome missegregation rates, consistent with less precise timing of separase activation.
CDK1 Phosphorylation — The Kinase-Dependent Brake
Active CDK1 phosphorylates separase at serine-1126 (human), which promotes separase association with 14-3-3 proteins — adapter proteins that sequester separase in an inactive complex independent of securin. At the metaphase-to-anaphase transition, APC/C-Cdc20-mediated Cyclin B1 degradation inactivates CDK1 simultaneously with securin degradation, removing the CDK1-dependent inhibition. This two-layer inhibitory system — securin (stoichiometric) and CDK1 phosphorylation (catalytic, through PP2A dephosphorylation when CDK1 falls) — ensures that full separase activation requires both securin degradation AND Cyclin B degradation, providing a logical AND gate that guards against separase activation in response to incomplete APC/C activation.
Rad21 Cleavage: Mechanism and Selectivity
Active separase cleaves Rad21 at two conserved cleavage sites in the N-terminal domain — both conforming to the consensus ExxR (where x is any residue and R is an essential arginine). The two cleavages release the N-terminal and C-terminal halves of Rad21, irreversibly opening the cohesin ring. The cleavage specificity for Rad21 over other cellular proteins is conferred partly by the cleavage site sequence, partly by phosphorylation of Rad21 serine-395 by CDK1 during mitosis (which makes Rad21 a better substrate), and partly by the spatial restriction of separase activity to the cohesin complex itself — separase is retained at centromeres and chromosome arms until activated. In meiosis, separase cleaves the meiotic kleisin Rec8 at the equivalent sites, but centromeric Rec8 is phosphorylated by Polo-like kinase and protected from dephosphorylation at meiosis I anaphase, making it a poor substrate until meiosis II.
Non-Cohesin Substrates and Roles
Separase cleaves additional substrates that contribute to anaphase and cell cycle progression. In budding yeast, separase cleaves the anaphase-entry inhibitor Slk19, which stabilises the anaphase spindle midzone. Separase cleaves kendrin/pericentrin at centrosomes, contributing to centriole disengagement after mitosis — licensing centrosome duplication in the next cell cycle. In human cells, separase cleaves CPAP/CENPJ at centrioles. The breadth of separase substrates suggests it functions as a general trigger of events that must occur at anaphase onset — an effector protease that executes the anaphase programme rather than solely cutting cohesin. Separase overexpression is documented in multiple cancers, where it may drive premature cohesin cleavage, chromosome instability, and aneuploidy.
Anaphase Chromosome Movement — Anaphase A + B Combined
Microtubules shorten
Microtubules shorten
ANAPHASE A (chromosome-to-pole)
Kinetochore MT depolymerisation at plus-end (Pacman) and minus-end (flux). Chromosomes move poleward at 1–2 µm/min. Spindle pole distance remains approximately constant.
ANAPHASE B (pole-to-pole)
Interpolar MT sliding by kinesin-5 + cortical dynein pulling. Poles move ~2–4 µm further apart. Operates simultaneously with anaphase A in most organisms.
Diagram: Rad21 cleavage releases sister chromatids; anaphase A and B forces drive their poleward transport and pole separation
Anaphase A: Kinetochore Microtubule Shortening and Chromosome-to-Pole Movement
Anaphase A describes the movement of chromosomes toward the spindle poles driven by kinetochore microtubule (k-MT) depolymerisation. It begins the instant cohesin is cleaved — the two released sister chromatids are immediately under the tension of amphitelic k-MT attachment to opposite poles, and once the cohesive link is gone, they move poleward. The movement rate — typically 1–2 µm per minute in human cells — is primarily determined by the rate of k-MT depolymerisation rather than by active motor-driven transport, though several molecular motors contribute to force generation and chromosome tracking along shrinking microtubule ends.
The Pacman Mechanism — Depolymerisation at the Kinetochore-Proximal Plus End
In the Pacman mechanism, the kinetochore tracks along the depolymerising plus end of a shrinking kinetochore microtubule — consuming the microtubule from its front end as it moves poleward, analogous to the Pac-Man arcade game character consuming the path ahead. The kinetochore remains attached to the fraying, curved protofilaments of the depolymerising plus end through its Ndc80 complex contacts, which provide both a structural grip on the microtubule lattice and a force-coupling mechanism that converts the free energy of GTP-tubulin hydrolysis and the conformational change of GDP-protofilament curling into poleward movement. The Hill sleeve model describes this coupling: the kinetochore acts as a sleeve around the microtubule, and the curling protofilaments of the depolymerising end provide a lever that pushes the kinetochore toward the pole.
Microtubule Flux and Minus-End Depolymerisation
Microtubule flux — the poleward movement of tubulin subunits along the microtubule lattice through continuous polymerisation at the plus end and depolymerisation at the minus end — contributes to chromosome poleward movement independently of kinetochore-proximal depolymerisation. During anaphase, the plus-end polymerisation component of flux ceases (the kinetochore releases from the stabilising influence that maintained dynamic instability during metaphase) but minus-end depolymerisation continues — effectively consuming the microtubule from the pole end, pulling the chromosome-attached plus end progressively closer to the pole. In Drosophila embryonic mitosis, flux accounts for approximately 80% of anaphase A poleward movement; in human somatic cells, the Pacman mechanism is relatively more prominent. Both mechanisms operate simultaneously and additively in most systems studied.
Motor Proteins at the Kinetochore During Anaphase A
Several molecular motors contribute to chromosome-to-pole movement alongside microtubule depolymerisation. CENP-E (kinesin-7) is a plus-end-directed motor that keeps chromosomes associated with plus-end-rich kinetochore regions and contributes to congression during prometaphase; during anaphase, CENP-E assists poleward tracking. Cytoplasmic dynein — a minus-end-directed motor — is present at kinetochores during early mitosis and is thought to contribute a fast, early pulling force during anaphase onset before transitioning chromosomes to the slower depolymerisation-driven tracking mode. Kinesin-13 (MCAK/KIF2) depolymerising kinesins accumulate at centromeres and contribute to kinetochore microtubule depolymerisation during anaphase, though their main activity for error correction occurs earlier in mitosis.
Anaphase B: Spindle Pole Separation and Elongation
Anaphase B describes the separation of the spindle poles themselves — the increase in distance between the two MTOCs that drives the two chromosome sets apart beyond the contribution of chromosome-to-pole movement alone. It overlaps temporally with anaphase A but is mechanistically distinct: rather than shortening kinetochore microtubules, anaphase B extends the interpolar region of the spindle through the action of motors on overlapping antiparallel microtubules and cortical force generators that pull each pole toward the cell surface.
Kinesin-5 (Eg5/KIF11) — Pushing Poles Apart
Bipolar kinesin-5 tetramers crosslink antiparallel interpolar microtubules from the two half-spindles and walk toward both plus ends simultaneously — sliding the antiparallel bundles outward and pushing the poles apart. This is the same mechanism that separates centrosomes during prophase. Inhibition of kinesin-5 (e.g., by the drug monastrol or clinical inhibitors like ispinesib) collapses anaphase B spindle elongation and is the basis for exploring kinesin-5 inhibitors as anti-mitotic cancer therapeutics.
Cortical Dynein — Pulling Poles Outward
Cytoplasmic dynein anchored at the cell cortex through the LGN-NuMA complex and Gαi proteins captures astral microtubules growing from each spindle pole and walks toward the minus end — generating a pulling force that moves each pole toward the nearest cell cortex. Cortical dynein is the dominant driver of anaphase B in some cell types (particularly in asymmetrically dividing cells where spindle orientation matters). Its asymmetric activity in cells with one large and one small blastomere ensures that the spindle is properly positioned for unequal cell division.
Kinesin-6 (MKLP1) and the Central Spindle
Kinesin-6 (MKLP1/CHO1) is a plus-end-directed motor that accumulates in the central spindle midzone during anaphase — crosslinking and bundling antiparallel microtubules at the spindle midzone and contributing to midzone organisation. Along with PRC1 (a microtubule bundling protein that selectively crosslinks antiparallel MTs) and Aurora B kinase, MKLP1 organises the central spindle into the structure that will specify the cleavage furrow position and support cytokinesis. MKLP1 also transports chromosomal passenger complex (CPC) components from kinetochores to the midzone during anaphase — relocating Aurora B to its cytokinesis functions at the midbody.
Motor Proteins Orchestrating Anaphase: A Mechanistic Summary
The mechanics of anaphase depend on the coordinated activity of multiple molecular motors working at different spindle locations, driving forces in complementary directions, and being activated or recruited at the onset of anaphase by the same CDK1 inactivation and separase activation that triggers chromosomal release. Understanding which motor does what — and in which direction at which location — is the key to answering the mechanistic questions about anaphase that appear in cell biology examinations and research assessments at every level.
| Motor Protein | Family / Type | Spindle Location | Direction | Anaphase Function |
|---|---|---|---|---|
| Kinesin-5 (Eg5/KIF11) | Kinesin, bipolar tetramer | Interpolar MTs, midzone | Plus-end (outward) | Anaphase B: slides antiparallel MTs apart, pushing poles away from each other. Also maintains bipolar spindle integrity throughout mitosis. |
| Cytoplasmic Dynein | Dynein (minus-end directed) | Cell cortex (via LGN-NuMA), kinetochores, spindle poles | Minus-end (inward) | Anaphase B: cortical dynein pulls poles toward cell edges. Also strips Mad1/Mad2 from kinetochores along k-MTs (SAC silencing at anaphase onset). |
| Kinesin-13 (MCAK/KIF2) | Kinesin, depolymerising | Centromeres, spindle poles | Depolymerises; moves toward plus ends to destabilise | Anaphase A: promotes k-MT depolymerisation at kinetochore and pole ends, contributing to chromosome-to-pole movement. Also central to error correction at metaphase. |
| Kinesin-7 (CENP-E) | Kinesin, plus-end directed | Kinetochore outer domain | Plus-end | Anaphase A: assists chromosome tracking along depolymerising k-MT plus ends. Primary role in congression to the metaphase plate but contributes to chromosome movement during anaphase A. |
| Kinesin-6 (MKLP1) | Kinesin, plus-end directed | Central spindle midzone | Plus-end | Anaphase B: bundles antiparallel MTs at midzone, contributes to central spindle elongation. Transports Aurora B to midzone for CPC reassignment to cytokinesis role. |
| Kinesin-4 (KIF4A) | Kinesin, plus-end directed | Chromosome arms → midzone | Plus-end | Suppresses MT dynamics at midzone plus ends, promoting central spindle stability during anaphase. Works with PRC1 to organise antiparallel MT overlaps at the midzone. |
| Dynein (Kinetochore pool) | Dynein | Kinetochores (early anaphase) | Minus-end (poleward) | Early anaphase A: provides fast initial poleward movement before slower depolymerisation-coupled tracking takes over. Stripped from kinetochores by dynein transport along k-MTs during anaphase. |
Spindle Assembly Checkpoint Satisfaction: The Permission Signal for Anaphase
Anaphase cannot begin until the spindle assembly checkpoint is fully satisfied — a requirement that every chromosome must be correctly bioriented on the spindle before cohesin cleavage is licensed. Understanding SAC satisfaction at the molecular level is as important as understanding anaphase mechanics, because SAC bypass (weakened or absent checkpoint response) is one of the primary drivers of chromosome missegregation in cancer cells.
What “Satisfied” Means at the Molecular Level
SAC satisfaction is not a positive signal generated by correct attachment — it is the cessation of the inhibitory signal generated by incorrect or absent attachment. Each unattached or incorrectly attached kinetochore catalytically converts cytoplasmic Mad2 (open, inactive conformation) into kinetochore-activated closed-Mad2, which associates with Cdc20 and BubR1-Bub3 to form the Mitotic Checkpoint Complex. The MCC is a potent inhibitor of APC/C-Cdc20. As long as any kinetochore is unattached, MCC is continuously generated — overwhelming any APC/C activity. When all kinetochores achieve amphitelic biorientation under tension, the catalytic production of MCC ceases simultaneously at all kinetochores.
MCC disassembly then proceeds through two mechanisms: cytoplasmic dynein-mediated stripping of Mad1 and closed-Mad2 from kinetochores along kinetochore microtubules (a transport process requiring dynein processivity along k-MTs) and phosphatase activity at kinetochores (PP1 recruited by KNL1, and PP2A-B56 recruited by BubR1) that reverses Aurora B kinase-dependent SAC phosphorylations on kinetochore proteins. The combination of halted MCC production and active MCC disassembly rapidly depletes the MCC pool, freeing Cdc20 to activate APC/C and trigger securin and Cyclin B degradation.
The speed of SAC silencing — from the last kinetochore achieving biorientation to detectable APC/C substrate degradation — is approximately 3–10 minutes in human cells, consistent with the time required for Cdc20 liberation and substrate ubiquitination and proteasomal degradation. This delay between SAC satisfaction and anaphase onset means that experimentally, applying tension to the last unattached kinetochore in a cell does not immediately produce chromatid separation — the downstream biochemistry has its own kinetics.
Error Correction Before Anaphase: Aurora B and the Geometry of Tension
Not every kinetochore-microtubule attachment that forms during prometaphase is correct. Syntelic attachments (both kinetochores of a chromosome attached to the same pole), merotelic attachments (a single kinetochore attached to both poles), and monotelic attachments (only one kinetochore attached) all produce incorrect chromosome orientations that would lead to unequal chromosome distribution if not corrected before anaphase. The error correction machinery — centred on Aurora B kinase — monitors attachment geometry through a tension-sensing mechanism and destabilises incorrect attachments, giving the kinetochore an opportunity to re-attach correctly.
Aurora B — The Tension Sensor and Error Correction Kinase
Aurora B kinase — the catalytic subunit of the chromosomal passenger complex (CPC), which also includes INCENP, Borealin, and Survivin — is concentrated at the inner centromere in a position that is geometrically placed to sense whether kinetochores are under amphitelic tension. The key substrates of Aurora B relevant to error correction are the Hec1/Ndc80 tail domain (phosphorylation of multiple serine residues reduces microtubule-binding affinity) and MCAK (Aurora B phosphorylation activates MCAK’s depolymerising activity). When a kinetochore is incorrectly attached — syntelic, merotelic, or monotelic — there is no inter-kinetochore tension pulling the two sister kinetochores apart. Without tension, the kinetochore remains close to the inner centromere and within Aurora B’s phosphorylation range. Aurora B phosphorylates Hec1 and MCAK, reducing k-MT stability and allowing microtubule release and re-attachment — potentially in the correct orientation.
When biorientation is achieved, the two sister kinetochores are pulled outward by amphitelic tension — increasing inter-kinetochore distance and physically moving kinetochores away from the Aurora B concentration at the inner centromere. This spatial separation reduces Hec1 phosphorylation (because Aurora B’s substrates are beyond its effective phosphorylation range, while PP1 and PP2A dephosphorylate Hec1 constitutively at the kinetochore-distal locations), stabilising the k-MTs and locking in the correct bioriented attachment. This elegant tension-sensitive mechanism converts a physical displacement (kinetochore movement under tension) into a biochemical stability change (kinase-substrate separation → stabilised microtubule binding) without requiring direct molecular sensing of geometry — the geometry is sensed through force and translated into chemistry through spatial kinase-substrate relationships.
Merotelic kinetochore attachment — where a single kinetochore is attached to microtubules from both spindle poles — is the most frequently occurring attachment error in mammalian cells and the most clinically significant because it is invisible to the spindle assembly checkpoint. The SAC monitors kinetochore occupancy by microtubules: an unattached kinetochore activates the checkpoint; a kinetochore with microtubules attached does not, regardless of whether those microtubules come from one or both poles. A merotelically attached kinetochore has microtubule occupancy from both poles — fulfilling the SAC occupancy requirement — but cannot generate proper amphitelic tension because the pulling forces are not opposed from a single direction.
During anaphase, a merotelically attached chromosome receives pulling forces from both poles simultaneously. The stronger set of attachments determines the direction of movement — most merotelically attached chromosomes are resolved during anaphase by the progressive depolymerisation of the minority-pole microtubule connections — but a subset remain as lagging chromosomes that are incorporated into micronuclei at telophase. Aurora B-dependent correction before anaphase is the primary mechanism reducing merotelic error rates; cells with reduced Aurora B activity show dramatically increased merotelic attachment frequency and lagging chromosome rates.
Lagging Chromosomes, Anaphase Bridges, and Micronuclei
Two classes of anaphase abnormality are directly observable in fluorescence microscopy of dividing cells: lagging chromosomes and anaphase bridges. Both represent failure of accurate chromosome segregation and both, if not resolved before cytokinesis, produce micronuclei — small, aberrant nuclear structures adjacent to the main daughter nucleus that encapsulate mis-segregated chromosomal material and are associated with genomic instability, nuclear envelope rupture, and chromothripsis.
A lagging chromosome during anaphase is not merely an isolated cell biology curiosity — it is the cellular origin event for chromothripsis, complex chromosomal rearrangements, and the copy number variations that drive cancer evolution in multiple tumour types.
Principle established through micronucleus live-cell imaging studies and single-cell sequencing of chromothriptic genomes — connecting anaphase errors to complex cancer genomic landscapes
The relationship between chromosomal instability and the rate of anaphase errors is near-linear in cancer cell lines. Cells with high chromosomal instability divide with visible lagging chromosomes in approximately 10–15% of divisions — compared to less than 1% in normal diploid cells.
Observation from chromosome segregation studies in CIN-positive cancer cell lines — quantifying the per-division anaphase error rate that sustains chromosomal instability
Lagging Chromosomes
Single chromosomes trailing behind the two main chromosome masses in anaphase — most commonly from unresolved merotelic attachment. Frequency varies: ~1 in 100,000 divisions in normal diploid human cells; 1 in 10–20 in CIN-positive cancer lines. If incorporated into micronuclei, chromosomal DNA is susceptible to nuclear envelope rupture and TREX1 nuclease-mediated fragmentation — producing chromothripsis.
Anaphase Bridges
Chromatin threads connecting the two separating chromosome masses — from incomplete cohesin removal, unreplicated DNA, or dicentric chromosomes. Bridges broken by the cleavage furrow during cytokinesis produce double-strand breaks that generate chromosome fusions, deletions, and breakage-fusion-bridge cycles — a mechanism driving progressive genomic instability in cancer evolution.
Micronuclei
Small, nuclear-envelope-surrounded structures containing mis-segregated chromosomes or chromosome fragments, formed at telophase from lagging chromosomes or chromatin bridges. Micronuclear DNA frequently undergoes chromothripsis — simultaneous pulverisation and random reassembly of the encapsulated chromosome — producing complex chromosomal rearrangements in a single cell division.
Of human embryos formed after IVF show chromothripsis attributable to anaphase errors
Studies using single-cell sequencing of preimplantation embryos have revealed that chromosome catastrophe events — including chromothripsis attributable to micronucleus formation from anaphase errors — occur in a substantial minority of early cleavage-stage human embryos. This represents one of the most direct connections between anaphase biology and clinical reproductive outcomes, linking mechanistic chromosome segregation research to the interpretation of preimplantation genetic testing results.
Anaphase in Meiosis I: Homologue Separation and the Unique Arm-Specific Cohesin Cleavage
Anaphase I in meiosis is mechanistically related to mitotic anaphase but achieves a fundamentally different outcome: instead of separating sister chromatids (as in mitosis), it separates homologous chromosomes — one member of each pair (each consisting of two sister chromatids held together) moves to each pole. This distinction requires two meiosis-specific modifications to the anaphase programme: a different cohesin subunit (Rec8 instead of Rad21), a protection mechanism that limits separase cleavage to arm cohesin (leaving centromeric cohesin intact), and a unique kinetochore co-orientation that directs both sister kinetochores of a bivalent toward the same pole.
Meiotic Cohesin — Rec8 Replaces Rad21
Meiotic cells replace the mitotic kleisin subunit Rad21 with Rec8 — a meiosis-specific paralogue that incorporates into cohesin complexes alongside the meiotic variants STAG3 (replacing SA1/SA2) and SMC1β (replacing SMC1α at least partially). Rec8-containing cohesin holds sister chromatids together from S phase through both meiotic divisions and additionally holds homologues together at chiasmata during prophase I through metaphase I. The choice of Rec8 versus Rad21 as the cleavage target matters biologically because Rec8’s phosphorylation pattern determines its susceptibility to separase: Rec8 on chromosome arms is phosphorylated by DDK (Dbf4-dependent kinase) and Polo-like kinase 1, making it a good separase substrate; centromeric Rec8 is specifically protected by the phosphatase PP2A recruited by Shugoshin-2 (Sgo2/SGOL2) — kept dephosphorylated and therefore separase-resistant through anaphase I.
Shugoshin-2 and the Two-Step Cohesin Cleavage Programme
Shugoshin-2 (Sgo2/SGOL2) is the meiosis-specific protector of centromeric cohesin during meiosis I anaphase. It recruits PP2A to the pericentromeric region, where PP2A counteracts the kinase-dependent phosphorylation of Rec8 that marks it for separase cleavage. As a result, when separase is activated at meiotic anaphase I, it cleaves Rec8 on chromosome arms (dephosphorylation-unprotected) but cannot cleave centromeric Rec8 (PP2A-protected). This selective cleavage releases the chiasmata that held homologues together (chiasmata are maintained by arm cohesin, not centromeric cohesin) — allowing homologue separation — while maintaining sister chromatid cohesion at centromeres until anaphase II. The two-step design is elegant: one cohesin, one separase, but spatially regulated cleavage by differential phosphorylation produces the sequential chromosome separation events that characterise meiosis.
Kinetochore Co-Orientation (Syntely) at Meiosis I
In mitosis, the two sister kinetochores of each chromosome are oriented toward opposite poles (amphitely) — this is the biorientation that the SAC monitors. In meiosis I, the two sister kinetochores of each dyad must face the SAME pole — a geometry called co-orientation or syntely in the meiotic context. This requires a meiosis-specific kinetochore architecture that fuses the two sister kinetochores into a functional unit with a single microtubule attachment face. In budding yeast, the protein Monopolin (Mam1/Csm1/Lrs4) crosslinks the two sister kinetochores, creating a single attachment face. In mammals, MEIKIN (a meiosis-specific kinase-inactive pseudo-kinase) associates with the inner kinetochore and recruits PLK1 to promote co-orientation. Disruption of co-orientation — converting meiosis I kinetochore geometry to amphitelic — causes sister chromatids to separate at meiosis I instead of homologues, producing aneuploid products with unpaired chromatids.
Spindle and Force Mechanics in Meiosis I Anaphase
The spindle mechanics of meiosis I anaphase are analogous to mitosis — kinesin-5-driven interpolar MT sliding for pole separation (anaphase B equivalent) and k-MT depolymerisation for chromosome-to-pole movement (anaphase A equivalent). However, the moving objects are bivalents (two chromatids moving together toward one pole) rather than individual chromatids. The bi-lobed kinetochore structure of the co-oriented meiotic bivalent must maintain integrity as a single unit throughout anaphase I poleward movement — the cohesion that fuses the sister kinetochores into a single functional unit must be maintained until the chromatid-separation anaphase II. Loss of co-orientation fusion at any point during anaphase I would prematurely expose both sister kinetochores to microtubule capture from both poles — producing random sister chromatid segregation within the bivalent and an aneuploid meiotic product.
Anaphase in Meiosis II: Sister Chromatid Separation Completing the Meiotic Programme
Meiosis II is functionally equivalent to a mitotic division — separating sister chromatids from each other rather than homologues — and its anaphase (anaphase II) proceeds through the same molecular mechanism as mitotic anaphase: APC/C-Cdc20-mediated securin degradation, separase activation, and Rec8 kleisin cleavage. The key difference from anaphase I is that it is now the centromeric Rec8 that is cleaved — because the arm cohesin was already removed at anaphase I and the centromeric protection by Sgo2-PP2A was removed during the telophase I-to-meiosis II transition.
Anaphase Errors, Chromosomal Instability, and Disease
The consequences of anaphase errors extend from individual cells to entire organisms. In somatic cells, anaphase missegregation errors produce aneuploid daughter cells that either die from the consequences of chromosomal imbalance, survive with a selective growth disadvantage, or — in the context of cancer — survive with a selective growth advantage if the aneuploid state disrupts tumour suppressor dosage or amplifies oncogene copy number. In meiotic cells, anaphase errors produce aneuploid gametes that, if fertilised, produce aneuploid embryos — the most common cause of spontaneous miscarriage in humans and the source of viableaneuploid conditions including Down syndrome, Edwards syndrome, Turner syndrome, and Klinefelter syndrome.
Anaphase error sources and their relative contribution to human aneuploidy
Chromosomal Instability (CIN) and Anaphase Errors
Chromosomal instability — the ongoing, elevated rate of chromosome gains and losses in cancer cells — is sustained by persistent anaphase segregation errors. CIN cancers divide with lagging chromosomes in 10–15% of divisions, compared to under 1% in normal diploid cells. The molecular causes include merotelic attachment excess (from centrosome amplification, cohesion fatigue, or Aurora B deregulation), weakened SAC (allowing premature anaphase with residual incorrect attachments), and defective sister chromatid cohesion establishment. CIN produces intratumour genetic heterogeneity — diverse subclones with different aneuploid states — which drives tumour evolution, therapy resistance, and metastatic potential. The connection between anaphase error rate and cancer aggressiveness is one of the strongest arguments for targeting chromosome segregation as a cancer therapeutic approach.
Maternal Age and Meiotic Anaphase Errors
The most clinically significant consequence of anaphase error biology is the maternal-age-dependent increase in oocyte aneuploidy — from approximately 10–15% at age 25 to >40% at age 40–45. The primary mechanism is progressive depletion of Rec8-cohesin over the decades of diplotene arrest in primary oocytes (which enter meiosis I during fetal development and arrest before birth). Without new cohesin synthesis replacing depleted cohesin, arm cohesin becomes insufficient to maintain chiasma integrity at metaphase I, homologues prematurely separate (chiasma dissolution), and anaphase I non-disjunction produces aneuploid secondary oocytes. This cohesin insufficiency model, supported by cohesin gene knockout studies in mice and by cohort studies of human oocyte aneuploidy rates, explains why maternal age is the dominant risk factor for trisomy 21 and other viable aneuploidies in liveborn children.
Trisomy From Meiotic Anaphase Non-Disjunction
Non-disjunction — the failure of chromosomes to separate correctly during meiotic anaphase I or II — produces gametes with 24 chromosomes (n+1) instead of 23. If fertilised by a normal 23-chromosome gamete, the resulting zygote has 47 chromosomes — trisomy. Trisomy 21 (Down syndrome, 1 in 700 live births), trisomy 18 (Edwards syndrome, 1 in 5,000), and trisomy 13 (Patau syndrome) are the major viable autosomal trisomies; sex chromosome aneuploidies (47,XXY Klinefelter syndrome; 47,XXX; 45,X Turner syndrome) arise from gonosomal non-disjunction. Approximately 95% of trisomy 21 cases arise from maternal meiosis I non-disjunction, most commonly attributable to reduced chiasma formation and cohesion weakness at anaphase I.
Anti-Mitotic Drugs and Anaphase Arrest
Many cancer chemotherapy agents exploit anaphase biology. Taxanes (paclitaxel, docetaxel) stabilise microtubules, preventing the depolymerisation required for both anaphase A chromosome movement and spindle disassembly — arresting cells in mitosis and activating apoptosis. Vinca alkaloids (vincristine, vinblastine) depolymerise spindle microtubules, preventing chromosome attachment and triggering sustained SAC activation. Kinesin-5 inhibitors (ispinesib, filanesib) collapse anaphase B by preventing interpolar microtubule sliding. Aurora B inhibitors (barasertib/AZD1152) impair error correction — in cancer cells with already-elevated error rates, Aurora B inhibition pushes chromosome segregation errors to a lethal threshold. These therapeutic mechanisms all converge on disrupting the fidelity of the anaphase chromosome segregation programme in rapidly dividing tumour cells.
For students working on cell biology assignments, genetics essays, or research papers covering anaphase, chromosome segregation, spindle assembly, or the cell cycle more broadly, our specialist biological sciences team provides expert academic support at every level. Visit our biology assignment help page for undergraduate and postgraduate module support, biology research paper writing for extended written work, and dissertation support for doctoral-level research projects in chromosome biology, cell cycle regulation, or cancer genetics. For challenging anaphase and chromosome segregation topics that require deep mechanistic understanding, our challenging research topics service and personalised academic assistance provide targeted expert guidance.
Expert Cell Biology Academic Support at Every Level
From anaphase mechanism essays and chromosome segregation lab reports to full cell cycle regulation dissertations — specialist biological sciences writers across all academic levels and disciplines.
Frequently Asked Questions About Anaphase
Further academic support: biology assignment help · biology research papers · science writing services · chemistry homework help · research paper writing · literature review help · dissertation support · data analysis help · biostatistics help · critical analysis papers · proofreading and editing · personalised academic assistance · challenging research topics · research consulting · tutoring services